Details for 2016829306
Up to date per 01.04.2026
Actions
Details for 2016829306
Deleted
European Patent
12.09.2018 A
04.01.2023 B1
04.11.2015
US
201562250823 P
27.04.2016
US
201662328203 P
C12N 9/22 20060101AFI20191205BHEP
Owner
Crispr Therapeutics AGAeschenvorstadt 36 4051 BaselCH
Representative
No representatives present
Inventor
PORTEUS, Matthew, Hebdenc/o Crispr Therapeutics Inc. 610 Main Street Cambridge, MA 02139-3526US
ALLEN, Melanie, Ruthc/o Crispr Therapeutics 200 Sidney Street Cambridge, MA 02139US
COWAN, Chad, Albertc/o Crispr Therapeutics 200 Sidney Street Cambridge, MA 02139US
LUNDBERG, Ante, Svenc/o Crispr Therapeutics 200 Sidney Street Cambridge, MA 02139US
LIN, Michelle, I-chingc/o Crispr Therapeutics 200 Sidney Street Cambridge, MA 02139US
LI, Jeffreyc/o Crispr Therapeutics 200 Sidney Street Cambdridge, MA 02139US
NGUYEN, Thao, Thic/o Crispr Therapeutics 200 Sidney Street Cambridge, MA 02139US